PHR Form 144: minor insider sale of 307 shares disclosed

Rhea-AI Filing Summary

Phreesia, Inc. (PHR) has filed a Form 144 indicating that shareholder Yvonne Hui intends to sell 307 common shares, worth about $8,371.83, through Fidelity Brokerage on or about 15 July 2025. With 59,504,269 shares outstanding, the planned sale represents roughly 0.0005% of the company’s float.

The filing also discloses that the same seller disposed of 4,208 shares over the past three months in six separate transactions, generating gross proceeds of approximately $104,610. The 307 shares being registered for sale were acquired on 11 July 2025 via restricted-stock vesting and constitute compensation-related stock.

The notice includes the standard certification that the seller is unaware of any non-public adverse information about Phreesia. Given the very small size relative to total shares outstanding and the routine nature of Rule 144 sales, this event is unlikely to be materially impactful for investors.

Insights

Securities Analyst

TL;DR: 307-share Form 144 sale equals 0.0005% of float—immaterial for valuation.

This filing shows an insider planning to sell 307 PHR shares, following 4,208 shares already sold this quarter. At today’s quoted market value of roughly $8.4 k, the trade is negligible against 59.5 million shares outstanding. Such micro-scale liquidity events are routine and rarely influence price discovery or signal strategic shifts. The shares stem from recent restricted-stock vesting, so the sale appears to be ordinary compensation monetisation rather than a strategic exit. I view the disclosure as administratively necessary but financially neutral.

Corporate Governance Specialist

TL;DR: Routine Rule 144 filing—standard compliance; no governance red flags detected.

The seller certifies no possession of undisclosed adverse information and is following Rule 144 aggregation rules. The prior six sales and this proposed sale remain well below 1% of outstanding shares, indicating no control block erosion or concentrated disposal. The orderly disclosure supports transparency and aligns with insider-trading compliance frameworks. From a governance standpoint, the filing is compliant and immaterial.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	307	8371.83	59504269	07/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/11/2025	Restricted Stock Vesting	Issuer			307	07/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Yvonne Hui 1521 Concord Pike, Suite 301 PMB 221 Wilmington DE 19803	Common	04/15/2025	314	7549.56
Yvonne Hui 1521 Concord Pike, Suite 301 PMB 221 Wilmington DE 19803	Common	04/16/2025	418	9889.88
Yvonne Hui 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	04/21/2025	993	22880.51
Yvonne Hui 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	04/22/2025	1330	31521.00
Yvonne Hui 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	06/10/2025	582	16296.00
Yvonne Hui 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/07/2025	571	16473.35

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Phreesia (PHR) shares are being registered for sale in this Form 144?

The filing covers 307 common shares valued at about $8,371.83.

Who is the selling shareholder named in Phreesia’s Form 144?

The seller is Yvonne Hui, acting for her own account.

When is the anticipated sale date for the 307 PHR shares?

The shares are expected to be sold on 15 July 2025.

How many PHR shares has the same insider sold in the past three months?

The insider previously sold 4,208 shares across six transactions between 15 April and 7 July 2025.

What percentage of Phreesia’s outstanding shares does the 307-share sale represent?

Approximately 0.0005% of the 59,504,269 shares outstanding.

On which exchange will the shares be sold?

The filing lists the NYSE as the intended exchange.